NOXXON Pharma AG
Records under this name other than patents NOXXON Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,670,491 | MCP-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,273,480 | MCP-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,035,038 | SDF-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,822,369 | SDF-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,193,159 | MCP-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,314,223 | SDF-1 binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,387,221 | SDF-1 binding nucleic acids and the use thereof in cancer treatment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,093,934 | SDF-1 binding nucleic acids and the use thereof in cancer treatment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,590,424 | C5a binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,518,265 | C5a binding nucleic acids Formerly held In force · From the USPTO record | In force | From the USPTO record |